Soleus Capital Management, L.P. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001802630

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2025 · 75 positions · Total reported value $1.39B · Top-10 concentration 51.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.6% · 27 new · 36 cut · 27 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -6.9% · vs SPY -9.0% · Prev Value $2.90B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.4% · vs SPY -3.6% · Latest Value $2.81B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Soleus Capital Management, L.P. disclosed 75 equity positions with a combined reported value of $1.39B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 51.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were XBI ($113.54M), TGTX ($112.25M), NVCR ($98.39M). By sector, the heaviest allocations are Health Care 81.0%, Other 19.0%. Versus the prior quarter, allocation shifted toward Health Care (+6.3pp) and away from Other (-6.3pp).

Versus the prior quarter, Soleus Capital Management, L.P. opened 27 new positions, trimmed 36 and fully exited 27, a turnover rate of 72.6% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q1 2025 were STAA ($45.18M), BBNX ($41.56M), HOLX ($18.65M).

Of the 27 positions fully exited versus the prior quarter, the largest were AZN ($26.80M), QDEL ($24.37M), ALNY ($18.07M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • STAA STAAR SURGICAL CO · $45.18M
  • BBNX BETA BIONICS INC · $41.56M
  • HOLX HOLOGIC INC · $18.65M
  • ARGX ARGENX SE · $17.13M
  • SNY SANOFI SA · $12.55M
  • SLNO SOLENO THERAPEUTICS INC · $10.72M
  • KNSA KINIKSA PHARMACEUTICALS INTL · $10.43M
  • TNDM TANDEM DIABETES CARE INC · $9.50M

Fully Exited (vs previous quarter)

  • AZN ASTRAZENECA PLC · prev qtr: $26.80M
  • QDEL QUIDELORTHO CORP · prev qtr: $24.37M
  • ALNY ALNYLAM PHARMACEUTICALS INC · prev qtr: $18.07M
  • TAK TAKEDA PHARMACEUTICAL CO LTD · prev qtr: $15.62M
  • LLY ELI LILLY & CO · prev qtr: $9.00M
  • PCVX VAXCYTE INC · prev qtr: $8.11M
  • CSTL CASTLE BIOSCIENCES INC · prev qtr: $6.74M
  • VCEL VERICEL CORP · prev qtr: $4.43M · history

Insider Transactions (Form 4)

Latest Soleus Capital Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-11 Conversion Parabilis Medicines, Inc. 527,070 $9.48 SEC filing
2026-06-11 Buy Parabilis Medicines, Inc. 125,000 $20.00 SEC filing
2026-06-11 Buy Parabilis Medicines, Inc. 375,000 $20.00 SEC filing

All insider transactions →

Fund Profile

Soleus Capital Management, L.P. is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q3 2026 it reported 97 US equity positions with a combined value of $2.81B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-118942 (status: Approved), registered 2020-06-25
  • Regulatory AUM (Form ADV): $3.66B as of 2026-04-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 1 hedge funds

Portfolio Structure

  • 97 positions · $2.81B reported value (Q3 2026)
  • Top 10 holdings = 53.0% of reported value
  • Largest position: KRYS (KRYSTAL BIOTECH INC) at 13.5%
  • Average position size: $29.00M

Sector Tilt

  • Health Care 98.6%
  • Information Technology 0.0%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q3 2026: 27 new, 28 added, 36 reduced, 27 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.0%
Other 19.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.40M $113.54M 8.18%
8.18%
Reduce
2 2.85M $112.25M 8.08%
8.08%
Add
3 5.52M $98.39M 7.08%
7.08%
Add
4 441.76K $79.65M 5.74%
5.74%
Add
5 1.08M $76.30M 5.49%
5.49%
Add
6 12.48M $53.91M 3.88%
3.88%
Hold
7 7.09M $50.41M 3.63%
3.63%
Add
8 155.39K $47.90M 3.45%
3.45%
Add
9 2.56M $45.18M 3.25%
3.25%
New
10 1.14M $43.16M 3.11%
3.11%
Add
11 3.40M $41.56M 2.99%
2.99%
New
12 2.61M $32.05M 2.31%
2.31%
Add
13 2.42M $28.78M 2.07%
2.07%
Add
14 1.45M $26.75M 1.93%
1.93%
Reduce
15 2.57M $26.02M 1.87%
1.87%
Hold
16 7.79M $25.92M 1.87%
1.87%
Add
17 789.06K $24.09M 1.73%
1.73%
Add
18 1.07M $23.58M 1.70%
1.70%
Reduce
19 8.17M $22.54M 1.62%
1.62%
Hold
20 67.50K $22.36M 1.61%
1.61%
Add
21 274.27K $20.92M 1.51%
1.51%
Reduce
22 1.13M $20.34M 1.47%
1.47%
Hold
23 302.00K $18.65M 1.34%
1.34%
New
24 28.94K $17.13M 1.23%
1.23%
New
25 385.82K $16.24M 1.17%
1.17%
Add
26 214.36K $15.20M 1.09%
1.09%
Add
27 224.68K $15.04M 1.08%
1.08%
Add
28 7.31M $14.33M 1.03%
1.03%
Hold
29 6.33M $13.85M 1.00%
1.00%
Hold
30 1.08M $12.98M 0.94%
0.94%
Add
31 814.65K $12.79M 0.92%
0.92%
Hold
32 226.22K $12.55M 0.90%
0.90%
New
33 6.98M $11.17M 0.80%
0.80%
Hold
34 150.00K $10.72M 0.77%
0.77%
New
35 469.50K $10.43M 0.75%
0.75%
New
36 153.03K $10.04M 0.72%
0.72%
Add
37 816.61K $10.03M 0.72%
0.72%
Reduce
38 601.92K $9.82M 0.71%
0.71%
Reduce
39 496.04K $9.50M 0.68%
0.68%
New
40 285.00K $9.16M 0.66%
0.66%
Add
41 56.30K $8.77M 0.63%
0.63%
Reduce
42 169.00K $8.17M 0.59%
0.59%
Reduce
43 7.29M $7.95M 0.57%
0.57%
Hold
44 303.58K $7.43M 0.54%
0.54%
Reduce
45 450.50K $6.92M 0.50%
0.50%
Reduce
46 4.80M $6.72M 0.48%
0.48%
Hold
47 1.49M $6.43M 0.46%
0.46%
Hold
48 39.00K $6.21M 0.45%
0.45%
New
49 935.91K $5.64M 0.41%
0.41%
Reduce
50 117.00K $4.74M 0.34%
0.34%
New

FAQ

What did Soleus Capital Management, L.P. buy in 2025-Q1?

In its 2025-Q1 13F filing, Soleus Capital Management, L.P. reported 75 equity positions worth $1.39B in aggregate; its largest disclosed positions were XBI ($113.54M), TGTX ($112.25M), NVCR ($98.39M).

How large is Soleus Capital Management, L.P.'s portfolio?

Soleus Capital Management, L.P. reported $1.39B of long equity holdings across 75 positions as of 2025-Q1. Top-10 holdings account for 51.9% of reported value.

What is Soleus Capital Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/soleus-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →